These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36326309)

  • 1. The efficacy of anakinra compared to standard care of treatment for COVID-19: a meta-analysis.
    Malık H; Bınt Abdul Jabbar H; Latıf F; Sarfraz A; Sarfraz Z; Sarfraz M
    Turk J Med Sci; 2022 Jun; 52(3):547-553. PubMed ID: 36326309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anakinra treatment efficacy in reduction of inflammatory biomarkers in COVID-19 patients: A meta-analysis.
    Naveed Z; Sarwar M; Ali Z; Saeed D; Choudhry K; Sarfraz A; Sarfraz Z; Felix M; Cherrez-Ojeda I
    J Clin Lab Anal; 2022 Jun; 36(6):e24434. PubMed ID: 35435272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.
    Maes B; Bosteels C; De Leeuw E; Declercq J; Van Damme K; Delporte A; Demeyere B; Vermeersch S; Vuylsteke M; Willaert J; Bollé L; Vanbiervliet Y; Decuypere J; Libeer F; Vandecasteele S; Peene I; Lambrecht B
    Trials; 2020 Jun; 21(1):468. PubMed ID: 32493441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study.
    Bozzi G; Mangioni D; Minoia F; Aliberti S; Grasselli G; Barbetta L; Castelli V; Palomba E; Alagna L; Lombardi A; Ungaro R; Agostoni C; Baldini M; Blasi F; Cesari M; Costantino G; Fracanzani AL; Montano N; Monzani V; Pesenti A; Peyvandi F; Sottocorno M; Muscatello A; Filocamo G; Gori A; Bandera A
    J Allergy Clin Immunol; 2021 Feb; 147(2):561-566.e4. PubMed ID: 33220354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anakinra for the treatment of COVID-19 patients: a systematic review and meta-analysis.
    Dahms K; Mikolajewska A; Ansems K; Metzendorf MI; Benstoem C; Stegemann M
    Eur J Med Res; 2023 Feb; 28(1):100. PubMed ID: 36841793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anakinra in hospitalized non-intubated patients with coronavirus disease 2019: a Systematic review and meta-analysis.
    Barkas F; Filippas-Ntekouan S; Kosmidou M; Liberopoulos E; Liontos A; Milionis H
    Rheumatology (Oxford); 2021 Dec; 60(12):5527-5537. PubMed ID: 33999135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial.
    CORIMUNO-19 Collaborative group
    Lancet Respir Med; 2021 Mar; 9(3):295-304. PubMed ID: 33493450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Anakinra Plus Standard of Care for Patients With Severe COVID-19: A Randomized Phase 2/3 Clinical Trial.
    Fanlo P; Gracia-Tello BDC; Fonseca Aizpuru E; Álvarez-Troncoso J; Gonzalez A; Prieto-González S; Freire M; Argibay AB; Pallarés L; Todolí JA; Pérez M; Buján-Rivas S; Ibáñez B;
    JAMA Netw Open; 2023 Apr; 6(4):e237243. PubMed ID: 37027155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESCAPE: An Open-Label Trial of Personalized Immunotherapy in Critically lll COVID-19 Patients.
    Karakike E; Dalekos GN; Koutsodimitropoulos I; Saridaki M; Pourzitaki C; Papathanakos G; Kotsaki A; Chalvatzis S; Dimakopoulou V; Vechlidis N; Paramythiotou E; Avgoustou C; Ioakeimidou A; Kouriannidi E; Komnos A; Neou E; Rovina N; Stefanatou E; Milionis H; Nikolaidis G; Koutsoukou A; Damoraki G; Dimopoulos G; Zoumpos V; Eugen-Olsen J; Akinosoglou K; Gatselis NK; Koulouras V; Gkeka E; Markou N; Netea MG; Giamarellos-Bourboulis EJ
    J Innate Immun; 2022; 14(3):218-228. PubMed ID: 34852352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of Survival by IL-6 in a Randomized Placebo-Controlled Trial of Anakinra in COVID-19 Cytokine Storm.
    Jackson LE; Khullar N; Beukelman T; Chapleau C; Kamath A; Cron RQ; Chatham WW
    Viruses; 2023 Sep; 15(10):. PubMed ID: 37896812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta analysis on the utility of Anakinra in severe COVID-19 disease.
    Mohamed Hussein AAR; Sayad R; Abdelshafi A; Hammam IA; Kedwany AM; Elkholy SA; Ibrahim IH
    Cytokine; 2023 Sep; 169():156311. PubMed ID: 37536222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open label trial of anakinra to prevent respiratory failure in COVID-19.
    Kyriazopoulou E; Panagopoulos P; Metallidis S; Dalekos GN; Poulakou G; Gatselis N; Karakike E; Saridaki M; Loli G; Stefos A; Prasianaki D; Georgiadou S; Tsachouridou O; Petrakis V; Tsiakos K; Kosmidou M; Lygoura V; Dareioti M; Milionis H; Papanikolaou IC; Akinosoglou K; Myrodia DM; Gravvani A; Stamou A; Gkavogianni T; Katrini K; Marantos T; Trontzas IP; Syrigos K; Chatzis L; Chatzis S; Vechlidis N; Avgoustou C; Chalvatzis S; Kyprianou M; van der Meer JW; Eugen-Olsen J; Netea MG; Giamarellos-Bourboulis EJ
    Elife; 2021 Mar; 10():. PubMed ID: 33682678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Inflammatory Cytokines (Interleukin-1 and Interleukin-6) as a Potential Biomarker in the Different Stages of COVID-19 (Mild, Severe, and Critical).
    Ghofrani Nezhad M; Jami G; Kooshkaki O; Chamani S; Naghizadeh A
    J Interferon Cytokine Res; 2023 Apr; 43(4):147-163. PubMed ID: 37062817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
    McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
    Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study.
    Kooistra EJ; Waalders NJB; Grondman I; Janssen NAF; de Nooijer AH; Netea MG; van de Veerdonk FL; Ewalds E; van der Hoeven JG; Kox M; Pickkers P;
    Crit Care; 2020 Dec; 24(1):688. PubMed ID: 33302991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anakinra was not associated with lower mortality in hospitalised COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials.
    Shang W; Zhang Y; Wang G; Han D
    Rev Med Virol; 2023 Mar; 33(2):e2418. PubMed ID: 36600551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current evidence on the use of anakinra in COVID-19.
    Khani E; Shahrabi M; Rezaei H; Pourkarim F; Afsharirad H; Solduzian M
    Int Immunopharmacol; 2022 Oct; 111():109075. PubMed ID: 35905562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.